ParambirSinghDulaiMD

Inflammatory Bowel Disease

Physician

Dr. Dulai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
259 E Erie St
Ste 1600
Chicago, IL 60611
Phone+1 312-695-5620

Fax+1 312-695-2729

University of California (San Diego) Medical CenterFellowship, Gastroenterology, 2017
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 2010 - 2014
Dayanand Medical College Class of 2009

Hyperbaric Oxygen for Ulcerative Colitis Start of enrollment: 2013 Aug 01
Terminated
Phase 2, Phase 3
Hyperbaric Oxygen Therapy for Ulcerative Colitis Flares Start of enrollment: 2017 Sep 07
Completed
Phase 2

PubMed

Placebo Rates in Crohn's Disease Randomized Clinical Trials: An Individual Patient Data Meta-Analysis.
Virginia Solitano, Malcolm Hogan, Siddharth Singh, Silvio Danese, Laurent Peyrin-Biroulet
Gastroenterology. 2025-02-01
Improvement in serum eosinophilia is observed in clinical responders to ustekinumab but not adalimumab in inflammatory bowel disease.
Emily C L Wong, Parambir S Dulai, John K Marshall, Vipul Jairath, Walter Reinisch
Journal of Crohn's & Colitis. 2025-01-11
Safety, Pharmacokinetics, and Clinical Efficacy of ADS051, a Neutrophil Modulator, in Ulcerative Colitis: Results of a Randomized Phase 1b Trial.
Jessica R Allegretti, Adam S Cheifetz, Parambir S Dulai, A C Stevens, Jillian Chapas-Reed
The American Journal of Gastroenterology. 2024-12-31

Journal Articles

Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
Leah Katta, Robert Hirten, Shannon Chang, Dana Lukin, Edward V Loftus, David Faleck, Arun Swaminath, William J Sandborn, Sashidhar Varma Sagi, Sunanda Kane, Prianka Ch..., Nature
Comparison of Multiplex Gastrointestinal Pathogen Panel and Conventional Stool Testing for Evaluation of Diarrhea in Patients with Inflammatory Bowel Diseases
Waseem Ahmad, Daniel Bouland, Nghia H Nguyen, David T Pride, Siddharth Singh, Parambir S Dulai, William J Sandborn, Brigid S Boland, Digestive Diseases and Sciences
Cell Trafficking Interference in Inflammatory Bowel Disease: Therapeutic Interventions Based on Basic Pathogenesis Concepts
Parambir S Dulai, William J Sandborn, Brigid S Boland, Derek R Patel, Inflammatory Bowel Diseases
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
Gursimran Kochhar, Justin Hartke, Sashidhar Varma Sagi, Edward V Loftus, Joseph Meserve, Robert Hirten, David Faleck, Shannon Chang, Dana Lukin, Farhad Peerani, Leah K..., Nature
No Benefit of Concomitant 5-Aminosalicylates in Patients with Ulcerative Colitis Escalated to Biologic Therapy: Pooled Analysis of Individual Participant Data from Cli...
Siddharth Singh, Parambir S Dulai, William J Sandborn, Nature
Join now to see all

Learn Best Practices for IBD Shared Decision-Making and Treatment SelectionFebruary 11th, 2025
Understanding a Novel Mechanism of Action in Ulcerative ColitisOctober 21st, 2024
Oxygen Therapy Offers Promising Results in People with Crohn’s FistulasFebruary 1st, 2023
Join now to see all